PLK3 and cancer: Cyclin-dependent kinase 1A (CDKN1A), and Polo-like kinase 3 (PLK3) are cell cycle inhibitors, but CDKN1A overexpression has also been associated with increased cell migration and cancer stem cell promotion [46].